About Elucida Oncology
Elucida Oncology is a company based in Santa Barbara (United States) founded in 2014. Elucida Oncology has raised $81.54 million across 4 funding rounds. Elucida Oncology operates in a competitive market with competitors including Abingdon Health, Sirnaomics, Acorda, Liquidia and Genedit, among others.
- Headquarter Santa Barbara, United States
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$81.54 M (USD)
in 4 rounds
-
Latest Funding Round
$44 M (USD), Series B
Jan 12, 2021
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Elucida Oncology
Elucida Oncology has successfully raised a total of $81.54M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $44 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Elucida Oncology
Investment portfolio details for Elucida Oncology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elucida Oncology
Detailed financials for Elucida Oncology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elucida Oncology Comparisons
Peer comparison for Elucida Oncology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elucida Oncology
Elucida Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Sirnaomics, Acorda, Liquidia and Genedit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| Locked | Locked | Locked |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| Locked | Locked | Locked |
Engineered particles & films for life and material sciences applications
|
|
| Locked | Locked | Locked |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| Locked | Locked | Locked |
Drug delivery systems to cell interiors are developed via nanosyringes.
|
Detailed competitors of Elucida Oncology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elucida Oncology
Complete news archive for Elucida Oncology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elucida Oncology
Elucida Oncology was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Elucida Oncology is headquartered in Santa Barbara, United States. It is registered at Santa Barbara, California, United States.
Elucida Oncology is a funded company, having raised a total of $81.54M across 4 funding rounds to date.
Elucida Oncology is a developer of a particle delivery platform using nanotechnology. The platform is called ultra-small C dot technology, it encapsulates near-infrared dye with a rigid silica shell which is coated with a layer of polyethylene glycol (PEG). PEG also acts as an ideal linker for a broad variety of ligands. The company claims a 95 clearance of C-dots through the renal system. The company has developed an Image-Guided Sentinel Lymph Node Mapping product, Nanoparticle Drug Conjugates, Nanoparticle Radiotherapeutic Conjugates, Multiplexing: Tumor Nerve Tissue, PET imaging, and others.
Elucida Oncology's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.